Nephrogenic Systemic Fibrosis Risk With New MRI Contrast To Be Reviewed
The FDA has asked a panel of outside experts to evaluate the risk of nephrogenic systemic fibrosis (NSF) with a new MRI contrasting agent proposed by Bayer AG.
Tag Archives: GE Healthcare
-
-
Nephrogenic Systemic Fibrosis (NSF) Lawsuit Set For Trial January 2011
Trial has been schedule to begin early next year for a lawsuit involving allegations that a gadolinium-based MRI contrast agent led to the development of nephrogenic systemic fibrosis (NSF), a…
-
FDA Warns Not to Use Some MRI Contrast Agents With Kidney Patients
The FDA is banning the use of three major brands of MRI contrast agent on patients with kidney problems, and is forcing other manufacturers to change their labels to bring more…
-
Aisys and Avance Anesthesia System Recall: Control Board Defect
A Class 1 medical device recall has been issued for GE Healthcare Aisys and Avance Anesthesia Systems, which can fail to provide ventilation for patients under the affects of anesthetics.
